Edition:
United Kingdom

BrightPath Biotherapeutics Co Ltd (4594.T)

4594.T on Tokyo Stock Exchange

279JPY
7:00am BST
Change (% chg)

¥0 (+0.00%)
Prev Close
¥279
Open
¥276
Day's High
¥288
Day's Low
¥276
Volume
298,100
Avg. Vol
673,276
52-wk High
¥968
52-wk Low
¥243

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Kenichi Nagai

45 2011 President, Chief Executive Officer, Representative Director

Yutaka Waki

57 2014 Chief Operating Officer, Director of Research Development, Director

Akira Yamada

58 2004 Director

Hirotaka Takeuchi

71 2015 Independent Director